These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

158 related articles for article (PubMed ID: 38409358)

  • 1. Elucidating Hedgehog pathway's role in HNSCC progression: insights from a 6-gene signature.
    Yang Y; Yang C; Yang Q; Lu S; Liu B; Li D; Li D; Zhang P; Xu P; Lang J; Zhou J
    Sci Rep; 2024 Feb; 14(1):4686. PubMed ID: 38409358
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A meta-validated immune infiltration-related gene model predicts prognosis and immunotherapy sensitivity in HNSCC.
    Ding Y; Chu L; Cao Q; Lei H; Li X; Zhuang Q
    BMC Cancer; 2023 Jan; 23(1):45. PubMed ID: 36639648
    [TBL] [Abstract][Full Text] [Related]  

  • 3. An angiogenesis-associated gene-based signature predicting prognosis and immunotherapy efficacy of head and neck squamous cell carcinoma patients.
    Chen B; Han Y; Sheng S; Deng J; Vasquez E; Yau V; Meng M; Sun C; Wang T; Wang Y; Sheng M; Wu T; Wang X; Liu Y; Lin N; Zhang L; Shao W
    J Cancer Res Clin Oncol; 2024 Feb; 150(2):91. PubMed ID: 38347320
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiomics data analyses to identify SLC25A17 as a novel biomarker to predict the prognosis and immune microenvironment in head and neck squamous cell carcinoma.
    Shi Y; Huang J; Hu Y; Shen Y
    BMC Bioinformatics; 2023 Jun; 24(1):269. PubMed ID: 37386359
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Survival-related indicators ALOX12B and SPRR1A are associated with DNA damage repair and tumor microenvironment status in HPV 16-negative head and neck squamous cell carcinoma patients.
    Li J; Tang LL; Ma J
    BMC Cancer; 2022 Jun; 22(1):714. PubMed ID: 35768785
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inflammatory response-related genes predict prognosis in patients with HNSCC.
    Jing SL; Afshari K; Guo ZC
    Immunol Lett; 2023 Jul; 259():46-60. PubMed ID: 37279805
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of RNA Modification-Associated Alternative Splicing Signature as an Independent Factor in Head and Neck Squamous Cell Carcinoma.
    Liu J; Deng W; Xiao Z; Huang X; Lin M; Long Z
    J Immunol Res; 2022; 2022():8976179. PubMed ID: 36157883
    [TBL] [Abstract][Full Text] [Related]  

  • 8.
    Chen L; Lin J; Lan B; Xiong J; Wen Y; Chen Y; Chen CB
    Comput Math Methods Med; 2022; 2022():5851755. PubMed ID: 36510584
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Integrated multi-omics analysis identifies CD73 as a prognostic biomarker and immunotherapy response predictor in head and neck squamous cell carcinoma.
    Shen A; Ye Y; Chen F; Xu Y; Zhang Z; Zhao Q; Zeng ZL
    Front Immunol; 2022; 13():969034. PubMed ID: 36466881
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel Pyroptosis-related long non-coding RNA signature for predicting the prognosis and immune landscape of head and neck squamous cell carcinoma.
    Zhou C; Shen Y; Jin Y; Shen Z; Ye D; Shen Y; Deng H
    Cancer Med; 2022 Dec; 11(24):5097-5112. PubMed ID: 35567376
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Ferroptosis-associated DNA methylation signature predicts overall survival in patients with head and neck squamous cell carcinoma.
    Xu Y; Hong M; Kong D; Deng J; Zhong Z; Liang J
    BMC Genomics; 2022 Jan; 23(1):63. PubMed ID: 35042463
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Machine learning developed a macrophage signature for predicting prognosis, immune infiltration and immunotherapy features in head and neck squamous cell carcinoma.
    Wang Y; Mou YK; Liu WC; Wang HR; Song XY; Yang T; Ren C; Song XC
    Sci Rep; 2024 Aug; 14(1):19538. PubMed ID: 39174693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a metabolic reprogramming-related signature associated with prognosis and immune microenvironment of head and neck squamous cell carcinoma by in silico analysis.
    Qiang W; Dai Y; Xing X; Sun X
    Cancer Med; 2022 Aug; 11(16):3168-3181. PubMed ID: 35301800
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Screening the key genes of prognostic value in the microenvironment for head and neck squamous cell carcinoma.
    Meng D; Liu T; Ma F; Wang M
    Medicine (Baltimore); 2021 Jan; 100(4):e24184. PubMed ID: 33530209
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Deciphering a Prognostic Signature Based on Soluble Mediators Defines the Immune Landscape and Predicts Prognosis in HNSCC.
    Chi H; Peng G; Song G; Zhang J; Xie X; Yang J; Xu J; Zhang J; Xu K; Wu Q; Yang G
    Front Biosci (Landmark Ed); 2024 Mar; 29(3):130. PubMed ID: 38538268
    [TBL] [Abstract][Full Text] [Related]  

  • 16. FOXD1 expression in head and neck squamous carcinoma: a study based on TCGA, GEO and meta-analysis.
    Huang J; Liang B; Wang T
    Biosci Rep; 2021 Jul; 41(7):. PubMed ID: 34269372
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a prognostic signature of autophagy, apoptosis and pyroptosis-related genes for head and neck squamous cell carcinoma: to imply therapeutic choices of HPV negative patients.
    Nan Z; Dou Y; Chen A; Wang K; Sun J; Meng Z; Neckenig M; Ai D; Liu S; Dong Z; Ma C; Cheng Y; Qu X
    Front Immunol; 2022; 13():1100417. PubMed ID: 36703967
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcriptome analysis reveals the link between lncRNA-mRNA co-expression network and tumor immune microenvironment and overall survival in head and neck squamous cell carcinoma.
    Zhong Z; Hong M; Chen X; Xi Y; Xu Y; Kong D; Deng J; Li Y; Hu R; Sun C; Liang J
    BMC Med Genomics; 2020 Mar; 13(1):57. PubMed ID: 32228580
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Establishment and validation of immune microenvironmental gene signatures for predicting prognosis in patients with head and neck squamous cell carcinoma.
    Wang J; Tian Y; Zhu G; Li Z; Wu Z; Wei G; Zhuang L; Li Z; Chen X; Zhang X; Zheng J; Cai G
    Int Immunopharmacol; 2021 Aug; 97():107817. PubMed ID: 34091115
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Identification of pyroptosis-related gene prognostic signature in head and neck squamous cell carcinoma.
    Li Z; Shen L; Li Y; Shen L; Li N
    Cancer Med; 2022 Dec; 11(24):5129-5144. PubMed ID: 35574984
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.